This role is pivotal for launching empasiprubart, argenx's second therapeutic asset, in the Multifocal Motor Neuropathy treatment landscape
Job Summary
This role is pivotal for launching empasiprubart, argenx's second therapeutic asset, in the Multifocal Motor Neuropathy treatment landscape.
The successful candidate will lead cross-functional execution to develop positioning, messaging, and a US HCP vaccination strategy while streamlining processes to reduce treatment delays.
The position offers an opportunity to join a purpose-driven organization that values innovation, collaboration, and delivering value to people living with rare diseases.
Matching Summary
This role is pivotal for launching empasiprubart, argenx's second therapeutic asset, in the Multifocal Motor Neuropathy treatment landscape.
Salary
Base: $196,000.00 - $269,500.00 USD annually; Bonus/Equity: Eligible for short-term and long-term incentive programs; Benefits: Comprehensive package including retirement savings and health benefits